WithdrawnNo phase
Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures
Key facts
- Who runs it
- Sarcoma Oncology Research Center, LLC
- Where
- Santa Monica, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 27 Jan 2023
- Ended
- 1 Jul 2024
- Type of study
- Observational
- Record updated
- 5 July 2024
- Why it stopped
- Inactive study
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Individuals must meet all of the inclusion criteria in order to be eligible to participate in the study, as follows:; Male or Female ≥ 18 years of age; Pathologically confirmed diagnosis of locally advanced unresectable or metastatic soft tissue sarcoma; Patients who are already scheduled for surgery; Ability to understand the purposes and risks of the study and has signed and dated a written informed consent form approved by the investigator's IRB/Ethics Committee; Willingness to comply with all study procedures and availability for the duration of the study
Who cannot take part
- Patients who do not meet inclusion criteria
- -
Where in United States
- Sarcoma Oncology Research CenterSanta Monica, United StatesNo longer taking part
About the trial
What the trial wants to find out
The objectives of the study is to evaluate the anti-tumor activity of autologous natural killer cells in cultures of cancer cells obtained from patient's own tumor.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 5 July 2024